Pharma stocks with low debt to look out for
News by Aliceblue News Desk
23 Sept 2025

Pharma stocks with low debt are considered financially stable. Low debt means the company has minimal borrowings, reducing interest burden and financial risk, which strengthens its balance sheet and operational flexibility.
Low debt means a company has minimal borrowings or financial obligations. It indicates lower interest payments, reduced financial risk, and stronger capacity to invest in growth or withstand market fluctuations.
Also Read: PNC Infratech: Stock jumps after winning ₹495 Cr order road project in the state of Bihar
Syschem (India)
On September 23, 2025, Syschem India Ltd opened at ₹58.00, up 0.19% from its previous close of ₹57.90. The stock reached a high of ₹60.79 and a low of ₹58.00. By 2:45 PM, it traded at ₹59.00, a 1.90% increase, with a market cap of ₹256.73 crore.
Syschem (India) Ltd has zero debt and a debt-to-equity ratio of 0.00, ensuring financial stability.
Syschem (India) Ltd (BSE: 531173), incorporated in 1993, manufactures active pharmaceutical ingredients (APIs), bulk drugs, and specialty solvents, including Amoxycillin, Ampicillin, Cloxacillin, Cephalexin, Cefixime, and Cefadroxil.
Transchem
On September 23, 2025, Transchem Ltd opened at ₹75.89, up 5.07% from its previous close of ₹72.23. The stock reached a high of ₹75.89 and a low of ₹66.10. By 2:52 PM, it traded at ₹71.00, a 1.70% decline, with a market cap of ₹86.90 crore.
Transchem Ltd has zero debt and a debt-to-equity ratio of 0.00, indicating strong financial stability.
Transchem Ltd (BSE: 500422), incorporated in 1976, was engaged in mushroom production and processing. Its export-oriented plant in Pune is now non-operational, and funds are temporarily invested in short-term treasury operations.
Also Read: GRSE: Stock jumps 6% after signing $6.24 Cr contract with German based firm
Chemo Pharma
On September 23, 2025, Chemo Pharma Laboratories Ltd opened at ₹121.40, up 0.50% from its previous close of ₹120.80. The stock reached a high of ₹122.00 and a low of ₹114.50. By 2:48 PM, it traded at ₹121.95, a 0.95% increase, with a market cap of ₹18.29 crore.
Chemo Pharma Laboratories Ltd has zero debt and a debt-to-equity ratio of 0.00, ensuring financial stability.
Chemo Pharma Laboratories Ltd (BSE: 506365), established in 1942, previously manufactured pharmaceuticals and bulk drugs. The company is now planning diversification, negotiating to acquire a sick company in power and chemicals sectors.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
FAQs
Q: Which 3 pharma stocks have low debt to look out for?
A: Syschem (India) Ltd, Chemo Pharma Laboratories Ltd, and Transchem Ltd are notable pharma stocks with low debt levels.
Q: Why are pharma stocks with low debt considered attractive for tracking?
A: Pharma stocks with low debt are financially stable, carry lower risk, and provide stronger potential for long-term growth.
Q: How does low debt benefit pharma companies in their operations?
A: Low debt reduces financial burden, lowers interest costs, and enables companies to invest more in research and expansion.

News Author
Aliceblue News Desk















